期刊文献+

基质金属蛋白酶与支气管哮喘气道重塑 被引量:4

Matrix metalloproteinases and airway remodeling of bronchial asthma
原文传递
导出
摘要 气道炎症和重塑是支气管哮喘(简称哮喘)的主要特征。细胞外基质(extracellular matrix,ECM)的降解和沉积失衡是导致呼吸道壁结构异常构建的重要原因,而基质金属蛋白酶(matrixmetalloproteinases,MMP)则是调节ECM代谢的主要限速酶。各种MMP及其抑制剂之间可以互相调节,也可作用于细胞因子等多种炎症因子,以增强或减弱其生物学效应。气道重塑的过程也是MMP在气道壁沉积的过程,因此对MMP及其抑制剂的深入研究,对哮喘炎症及气道重塑机制的进一步明确有着重要意义。本文着重就MMP的生物学特性以及它们在哮喘气道重塑中所起的作用进行综述。 Airway inflammation and remodeling are the main features of bronchial asthma(asthma). Extracellular matrix (ECM) degradation and sediment imbalance are the important reason of respiratory abnormal construction of airway wall,and matrix metalloproteinases(MMP) is the main rate-limiting enzyme for the regulation of ECM metabolism. Each MMP and their various inhibitors can not only interact mutually,but also act on cytokines and other inflammatory factors to increase or decrease their biological effects. Airway remodeling is a process of MMP deposition in the airway walls. Therefore, the study in depth of MMP and their inhibitors are of great significance to further clarify the mechanism of asthma inflammation and airway remodeling. This review focuses on the biologic characteristics of these enzymes and the role of MMP and their inhibitors in airway remodeling of asthma.
出处 《国际呼吸杂志》 2009年第11期672-676,共5页 International Journal of Respiration
关键词 基质金属蛋白酶 哮喘 气道重塑 Matrix metalloproteinases Asthma Airway remodeling
  • 相关文献

参考文献25

  • 1Greenlee K J, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007,87 : 69-98.
  • 2Gueders MM, Foidart JM, Noel A, et al. Matrix metalloproteinases (MMP) and tissue inhibitors of MMP in the respiratory traet: potential implieations in asthma and other lung diseases. Eur J Pharmaeol, 2006,533 : 133-144.
  • 3Shiomi T, Inoki I, Kataoka F, et al. Pericellular activation of proMMP-7 ( promatrilysin-1) through interaction with CD151. Lab Invest,2005,85:1489-1506.
  • 4Pascual RM,Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol,2005,116:477-486.
  • 5Elshaw SR, Henderson N, Knox AJ, et al. Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br J Pharmacol, 2004,142 : 1318-1324.
  • 6Cataldo DD, Gueders M, Munaut C, et al. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest, 2004,84 : 418-424.
  • 7Cho JY,Miller M, McElwain K, et al. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: Modulatiort by immurtostimulatory DNA. J Allergy Clin Immunol, 2006,117 : 618-625.
  • 8Lee KS,Min KH,Kim SR,et al. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am J Respir Crit Care Med, 2006,174 : 161-170.
  • 9Chu EK, Cheng J, Foley JS, et al. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells. Am J Respir Cell Mol Biol, 2006,35:628-638.
  • 10Goleva E, Hauk PJ, Boguniewicz J, et al. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol, 2007,120 : 1065-1072.

同被引文献86

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部